Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on ano-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders
摘要:
Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detailed structure-activity-relationship study, leading to the discovery of a new series of compounds with nanomolar IC50 values against CSF-1R without the inhibition of fibroblast growth factor receptors. One of the most promising hits, compound 29, potently inhibited CSF-1R kinase with an IC50 value of 0.7 nM, while it showed no inhibition to the same family member FMS-like tyrosine kinase 3. Compound 29 displayed excellent anti-inflammatory effects against RAW264.7 macrophages indicated by significant inhibition against the activation of the CSF-1R pathway with low cytotoxicity. In addition, compound 29 exhibited strong in vivo anti-inflammatory efficacy alongside favorable drug characteristics. This novel compound 29 may serve as a new drug candidate with promising applications in inflammatory disorders.
PYRIDINE DERIVATIVES USEFUL AS CYCLOOXYGENASE INHIBITOR
申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP1355885A1
公开(公告)日:2003-10-29
[EN] PYRIDINE DERIVATIVES USEFUL AS CYCLOOXYGENASE INHIBITOR<br/>[FR] DERIVES DE PYRIDINE UTILES EN TANT QU'INHIBITEURS DE CYCLO-OXYGENASE
申请人:FUJISAWA PHARMACEUTICAL CO
公开号:WO2002055502A1
公开(公告)日:2002-07-18
A compound of the formula (I), wherein R1 is hydrogen, halogen, carbymoyl, cyano, formuly, or lower alkyl optionally substituted with halogen, amino or a protected amino; R2 is hydrogen, halogen, cyano or lower alkoxy; R3 is phenyl or pyridyl, each of which is substituted with lower alkoxy; and R4 is lower alkoxy; provided that either R1 or R2 is hydrogen, then the other is other than hydrogen, or its salts, which are useful as a medicament.